首页|肠内补充双歧杆菌联合初乳口腔涂抹对极低出生体重儿喂养不耐受的预防作用

肠内补充双歧杆菌联合初乳口腔涂抹对极低出生体重儿喂养不耐受的预防作用

扫码查看
目的 探究肠内补充双歧杆菌联合初乳口腔涂抹对极低出生体重儿喂养不耐受的预防作用。方法 选取 2021 年 6 月~2023 年6 月收治的 76 例极低出生体重儿,按照随机数字法分为对照组(n=38)和研究组(n=38),其中对照组患儿采用初乳口腔涂抹,研究组患儿采用肠内补充双歧杆菌联合初乳口腔涂抹。评估两组患儿预防效果、生长情况以及免疫球蛋白水平。结果 两组患儿开奶时间比较,差异无统计学意义(P>0。05),研究组患儿喂养不耐受发生例数(4 例)、胃潴留发生次数(1。82±0。22)次、胃潴留量(4。50±0。45)ml明显少于对照组[16 例、(3。06±0。29)次、(9。38±0。71)ml],达到全肠道喂养的时间(18。65±2。79)d低于对照组(21。66±2。68)d且胃肠摄入能量(564。30±22。11)kJ/kg高于对照组(459。80±21。44)kJ/kg(P<0。05);研究组患儿恢复出生体重所用时间(5。41±1。20)d少于对照组(9。58±1。54)d,体重、身长、头围增长速度[(22。23±3。47)g/d、(0。89±0。15)cm/周、(0。60±0。09)cm/周]均高于对照组[(17。78±3。09)g/d、(0。76±0。11)cm/周、(0。55±0。10)cm/周)](P<0。05);治疗后研究组IgA、IgG、IgM[(0。012±0。003)、(10。01±0。45)、(0。022±0。004)g/L)]显著高于对照组[(0。006±0。002)、(9。83±0。26)、(0。019±0。002)g/L](P<0。05)。结论 肠内补充双歧杆菌联合初乳口腔涂抹对极低出生体重儿喂养不耐受预防效果较好,可有效改善患儿免疫球蛋白水平、生长速度。
Prophylactic effect of enteral bifidobacterium supplementation combined with oropharyngeal administration of colostrum on feeding intolerance in very low birth weight infants
Objective To explore the preventive effect of enteral bifidobacterium supplementation combined with oropharyngeal administration of colostrum on feeding intolerance in very low birth weight infants.Methods 76 very low birth weight infants enrolled in a hospital from June 2021 to June 2023 were selected and divided into the control group(n=38)and the study group(n=38)according to random number method.The control group was treated with oropharyngeal administration of colostrum,the study group was treated with enteral bifidobacterium supplementation combined with oropharyngeal administration of colostrum.The prophylactic effect,growth and immunoglobulin levels of the two groups were evaluated.Results There was no significant difference in the first milk-feeding time between the two groups(P>0.05).The number of cases of feeding intolerance(4 cases),the number of gastric retention[(1.82±0.22)times]and the amount of gastric retention[(4.50±0.45)ml]in the study group were significantly lower than those in the control group[16 cases,(3.06±0.29)times,(9.38±0.71)ml].The time to reach full intestinal feeding[(18.65±2.79)d]was lower than that of control group(21.66±2.68)d),and gastrointestinal energy intake[(564.3±22.11)kJ/kg]was higher than that of control group[(459.80±21.44)kJ/kg](P<0.05).The time to regain birth weight in the study group[(5.41±1.20)d]was less than that in the control group[(9.58±1.54)d].The growth rates of body weight,body length and head circumference[(22.23±3.47)g/d,(0.89±0.15)cm/w,(0.60±0.09)cm/w]were higher than those of control group[(17.78±3.09)g/d,(0.76±0.11)cm/w,(0.55±0.10)cm/w](P<0.05).After treatment,IgA,IgG and IgM in the study group[(0.012±0.003),(10.01±0.45),(0.022±0.004)g/L]were significantly higher than those in the control group[(0.006±0.002),(9.83±0.26),(0.019±0.002)g/L](P<0.05).Conclusion Enteral bifidobacterium supplementation combined with oropharyngeal administration of colostrum has a good effect on the prevention of feeding intolerance in very low birth weight infants,and can effectively improve the level of immunoglobulin and growth rate of infants,which is worthy of popularization and application.

Very low birth weight infantsFeeding intoleranceBifidobacteriumOropharyngeal administration of colostrum

何永辉、王妍、林蕾

展开 >

常德市妇幼保健院新生儿科,湖南常德 415000

极低出生体重儿 喂养不耐受 双歧杆菌 初乳口腔涂抹

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(5)
  • 20